Related Experiment Video
Updated: Feb 23, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Phenotypic Features and Longterm Outcomes of Pediatric Inflammatory Bowel Disease Patients with Arthritis and
Osnat Nir1,2, Firas Rinawi1,2, Gil Amarilyo1,2
1From the Sackler School of Medicine, Tel Aviv University, Tel Aviv; Institute of Gastroenterology, Nutrition and Liver Disease, Schneider Children's Medical Center; Rheumatology Unit, Schneider Children's Medical Center, Petach Tikva, Israel.
Insights
Pediatric inflammatory bowel disease (IBD) patients with joint pain show unique characteristics. Joint pain at diagnosis predicts colectomy in ulcerative colitis and future arthritis development in pediatric IBD.
Area of Science:
- Pediatric Gastroenterology
- Rheumatology
- Clinical Outcomes Research
Background:
- The natural history and clinical course of pediatric inflammatory bowel disease (IBD) with joint involvement remain underexplored.
- Understanding these associations is crucial for comprehensive patient management.
Purpose of the Study:
- To investigate the distinct phenotypic features of pediatric IBD patients experiencing joint involvement.
- To determine the clinical outcomes associated with arthritis and arthralgia in this population.
Main Methods:
- Retrospective review of medical records for pediatric IBD patients diagnosed between 2000 and 2016.
- Analysis of outcomes including time to first disease flare, hospitalization, surgery, and initiation of biologic therapy.
Main Results:
- Arthritis and arthralgia were observed in 12.3% and 14.6% of pediatric Crohn disease patients, respectively, and were more common in females.
- Patients with arthritis/arthralgia had lower rates of perianal disease but those with arthritis were more likely to receive biologic therapy.
- In ulcerative colitis (UC), arthralgia at diagnosis predicted higher colectomy rates and was a risk factor for developing arthritis during follow-up.
Conclusions:
- Pediatric IBD patients with arthritis exhibit distinct phenotypic characteristics.
- Arthralgia at diagnosis serves as a significant predictor for colectomy in UC and the development of arthritis in pediatric IBD patients during follow-up.
Objective:
The natural history of pediatric inflammatory bowel disease (IBD) patients with joint involvement has not been clearly described. Thus, we aimed to investigate phenotypic features and clinical outcomes of this distinct association.
Methods:
The medical records of patients with pediatric IBD diagnosed from 2000 to 2016 were reviewed retrospectively. Main outcome measures included time to first flare, hospitalization, surgery, and biologic therapy.
Results:
Of 301 patients with Crohn disease (median age 14.2 yrs), 37 (12.3%) had arthritis while 44 (14.6%) had arthralgia at diagnosis. Arthritis and arthralgia were more common in women (p = 0.028). Patients with arthritis and arthralgia demonstrated lower rates of perianal disease (2.7% and 4.5% vs 16.9%, p = 0.013), whereas patients with arthritis were more likely to be treated with biologic therapy (HR 2.05, 95% CI 1.27-3.33, p = 0.009). Of 129 patients with ulcerative colitis (UC; median age 13.7 yrs), 3 (2.3%) had arthritis and 16 (12.4%) had arthralgia at diagnosis. Patients with arthralgia were treated more often with corticosteroids (p = 0.03) or immunomodulator therapies (p = 0.003) compared with those without joint involvement. The likelihood to undergo colectomy was significantly higher in patients with arthralgia (HR 2.9, 95% CI 1.1-7.4, p = 0.04). During followup (median 9.0 yrs), 13 patients developed arthritis (3.3%). Arthralgia at diagnosis was a significant predictor for the development of arthritis during followup (HR 9.0, 95% CI 2.86-28.5, p < 0.001).
Conclusion:
Pediatric IBD patients with arthritis have distinct phenotypic features. Arthralgia at diagnosis is a predictor for colectomy in UC and a risk factor for the development of arthritis during followup.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

